We are live on ! Find out more
DNTH icon

Dianthus Therapeutics
DNTH

53 hedge funds and large institutions have $11.1M invested in Dianthus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more call options, than puts

Call options by funds: $10K | Put options by funds: $2K

7% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 15

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.39% less ownership

Funds ownership: 5.3% → 2.9% (-2.4%)

26% less funds holding

Funds holding: 72 → 53 (-19)

76% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 25

84% less capital invested

Capital invested by funds: $67.4M → $11.1M (-$56.3M)

Holders
53
Holders Change
-19
Holders Change %
-26.39%
% of All Funds
0.85%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
16
Reduced
15
Closed
25
Calls
$10K
Puts
$2K
Net Calls
+$8K
Net Calls Change
+$8K

Top Buyers

Rank Fund Capital Flow
1
HJMC
Hellman Jordan Management Company
Massachusetts
+$287K
2
Millennium Management
Millennium Management
New York
+$241K
3
Renaissance Technologies
Renaissance Technologies
New York
+$203K
4
LSA
Leonteq Securities AG
Switzerland
+$199K
5
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
+$143K

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$9.5M
2
RCM
RA Capital Management
Massachusetts
-$5.06M
3
TCM
TCG Crossover Management
California
-$3M
4
DTC
Deep Track Capital
Connecticut
-$2.61M
5
WP
Woodline Partners
California
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$46K +$28.5K +1,610 +27%
Northern Trust
27
Northern Trust
Illinois
$34.2K – – –
Morgan Stanley
28
Morgan Stanley
New York
$31.5K +$71.1K +4,018 +417%
Connor, Clark & Lunn Investment Management (CC&L)
29
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$29.9K -$12K -676 -12%
CCMU
30
Cheyne Capital Management (UK)
United Kingdom
$18.6K – – –
Goldman Sachs
31
Goldman Sachs
New York
$15K -$81.5K -4,606 -66%
TRCT
32
Tower Research Capital (TRC)
New York
$15K +$29K +1,639 +208%
EGM
33
Engineers Gate Manager
New York
$13.5K +$37.7K +2,131 New
FT
34
Fiduciary Trust
Massachusetts
$12.1K – – –
BRWA
35
B. Riley Wealth Advisors
Florida
$11.1K +$31K +1,750 New
Charles Schwab
36
Charles Schwab
California
$10.8K – – –
E
37
Ergoteles
New York
$8.61K -$103K -5,832 -81%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$6.34K -$35 -2 -0.2%
SG
39
StoneX Group
New York
$4.83K +$13.5K +765 New
RG
40
Rathbones Group
United Kingdom
$3.95K – – –
Citadel Advisors
41
Citadel Advisors
Florida
$3.09K -$35.9K -2,027 -81%
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$3K -$18 -1 -0.3%
Bank of America
43
Bank of America
North Carolina
$2.78K +$7.59K +429 +3,900%
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$2.27K +$602 +34 +10%
BAM
45
Belpointe Asset Management
Nevada
$2.17K +$6.09K +344 New
Barclays
46
Barclays
United Kingdom
$2.1K -$2.12K -120 -26%
Wells Fargo
47
Wells Fargo
California
$300 -$1.63K -92 -66%
Citigroup
48
Citigroup
New York
$291 +$35 +2 +5%
AF
49
Allworth Financial
California
$128 – – –
Dimensional Fund Advisors
50
Dimensional Fund Advisors
Texas
$60 – – –
1
2
3 4

DNTH Hedge Fund Activity: Q4 2022 in Review

53 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Dianthus Therapeutics (DNTH) for Q4 2022, worth a combined $11.1M — down 84% from $67.4M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of DNTH and 6 opened new positions — a net loss of 19 holders — while 15 trimmed existing stakes and 16 added.

The largest buyer was Hellman Jordan Management Company, adding an estimated $287K. The largest seller was Janus Henderson Group, exiting entirely with an estimated $9.5M sold.

  • 53 institutional investors held Dianthus Therapeutics (DNTH) as of Q4 2022, down from 72 in Q3 2022.
  • Funds reported $11.1M of Dianthus Therapeutics stock for Q4 2022, down 84% quarter-over-quarter.
  • 6 funds opened new Dianthus Therapeutics positions in Q4 2022 and 25 closed out, a net change of -19 holders.
  • The largest Dianthus Therapeutics buyer in Q4 2022 was Hellman Jordan Management Company, an estimated $287K added.
  • The largest Dianthus Therapeutics seller in Q4 2022 was Janus Henderson Group, an estimated $9.5M sold.

Based on aggregated 13F filings for Q4 2022.